IRON News and Press, Disc Medicine Inc. From 11/18/25

2025-11-18 17:58:48 ET Disc Medicine, Inc. (IRON) Stifel 2025 Healthcare Conference November 13, 2025 8:40 AM EST... Read the full article on Seeking Alpha For further details see: Disc Medicine, Inc. (IRON) Presents at Stifel 2025 Healthcare Conference Transcript

2025-11-06 12:19:30 ET More on Disc Medicine Disc Medicine: NDA Submission And CNPV For Bitopertin Further Boost Shareholder Value Disc Medicine, Inc. (IRON) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) Disc Medicine prices upsized...

Submitted a New Drug Application (NDA) for accelerated approval of bitopertin in erythropoietic protoporphyria (EPP) on September 29, 2025; Awarded the FDA Commissioner’s National Priority Voucher (CNPV), which is designed to shorten the expected NDA review period to 1-2 months from NDA ac...

WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced two poster p...

2025-10-21 04:29:18 ET Disc Medicine ( NASDAQ: IRON ) has announced the pricing of an upsized underwritten public offering of its common stock and pre-funded warrants, to generate approximately $225 million in gross proceeds for the company.... Read the full article on...

WATERTOWN, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the ...

2025-10-20 09:15:21 ET The last time I spoke about Disc Medicine ( IRON ) it was with respect to a Seeking Alpha article entitled " Disc Medicine: Rare Disease Biotech With Enormous Potential ". With respect to this article I noted that the company had achieved positive results ...

2025-10-20 07:09:54 ET More on Disc Medicine Disc Medicine, Inc. (IRON) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) Achieve, Disc, Revolution among winners of initial FDA national priority vouchers Seeking Alpha’s Quant Rat...

WATERTOWN, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the ...

Submitted a New Drug Application (NDA) for accelerated approval of bitopertin in erythropoietic protoporphyria (EPP) on September 29, 2025, and subsequently was awarded the FDA Commissioner’s National Priority Voucher (CNPV), a program designed to shorten the expected NDA review period to ...